Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Non-Current Debt (2016 - 2025)

STRATA Skin Sciences' Non-Current Debt history spans 11 years, with the latest figure at $13.4 million for Q3 2025.

  • For Q3 2025, Non-Current Debt fell 11.34% year-over-year to $13.4 million; the TTM value through Sep 2025 reached $13.4 million, down 11.34%, while the annual FY2024 figure was $15.2 million, 0.98% up from the prior year.
  • Non-Current Debt for Q3 2025 was $13.4 million at STRATA Skin Sciences, down from $15.3 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $15.3 million in Q2 2025 and bottomed at $497000.0 in Q2 2021.
  • The 5-year median for Non-Current Debt is $13.4 million (2025), against an average of $10.7 million.
  • The largest annual shift saw Non-Current Debt tumbled 71.26% in 2021 before it skyrocketed 1387.93% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $7.3 million in 2021, then increased by 2.15% to $7.5 million in 2022, then surged by 101.23% to $15.0 million in 2023, then rose by 0.98% to $15.2 million in 2024, then decreased by 11.57% to $13.4 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Non-Current Debt are $13.4 million (Q3 2025), $15.3 million (Q2 2025), and $15.2 million (Q1 2025).